Physician

Daniel Gradin, M.D.

According to 2025 Medicare claims, Daniel Gradin, M.D. (NPI: 1275859399) practices ophthalmology in the Longview-Kelso, WA market, with the plurality of this provider's patient population coming from Cowlitz, WA. This provider's primary affiliated billing organization is UNIVERSITY PROFESSIONAL SERVICES (NPI: 1962656868; TIN: 931257437) and primary practice location at 98632-4677. Gradin is affiliated with the OHSU Health Clinically Integrated Network (ACO ID: A4901), participating under the MSSP model.

Gradin's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 807 traditional Medicare patients, billed 2,420 HCPCS/CPT codes, and received $187,063 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 1,828 prescription claims across 486 beneficiaries totaling $86,937 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). DME data shows 40 claims. Open Payments data shows 2 records totaling $102. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $52,115 to $86,937. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	588	1,565	$208,171
2016	764	2,075	$253,634
2017	978	2,573	$260,679
2018	1,065	2,751	$283,910
2019	1,152	2,996	$311,132
2020	951	2,626	$257,453
2021	989	2,632	$230,003
2022	1,021	2,671	$213,443
2023	970	2,726	$231,486
2024	807	2,420	$187,063

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	271	997	$52,115
2016	261	928	$35,544
2017	283	1,098	$44,743
2018	318	1,234	$69,726
2019	379	1,399	$85,696
2020	423	1,747	$89,426
2021	439	1,863	$112,438
2022	482	1,878	$101,419
2023	475	1,806	$89,662
2024	486	1,828	$86,937

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	158	162	$10,152
2016	230	231	$12,631
2017	176	178	$9,629
2018	168	168	$9,191
2019	123	123	$7,829
2020	98	102	$6,794
2021	73	73	$4,925
2022	39	39	$2,317
2023	40	40	$2,970
2024	40	40	$3,090

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
92014	Established patient complete exam of visual system	394	394	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	179	215	$60
92083	Exam of visual field with extended testing	211	247	$44
92134	Imaging of retina	210	235	$28
92133	Imaging of optic nerve	250	253	$26

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	392	10,943	$14,337
Restasis	Cyclosporine	15	540	$11,080
Lumigan	Bimatoprost	21	740	$7,536
Travoprost	Travoprost	57	1,996	$7,509
Latanoprost	Latanoprost	591	26,396	$5,584

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
V2020	Frames, purchases	N	27	27	$1,728
V2303	Spherocylinder, trifocal, plano to plus or minus 4.00d sphere, .12-2.00d cylinder, per lens	N	13	13	$1,362

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$102	Alcon Vision LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Daniel Gradin, M.D.?

Tedicare shows public-source Medicare data for Daniel Gradin, M.D. (NPI 1275859399), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Daniel Gradin, M.D. have ACO affiliation data?

Daniel Gradin, M.D. is shown with ACO affiliation data for OHSU Health Clinically Integrated Network (MSSP, ACO ID A4901).

What billing organization is linked to Daniel Gradin, M.D.?

Daniel Gradin, M.D. is linked to UNIVERSITY PROFESSIONAL SERVICES (billing NPI 1962656868) in the available physician profile data.

Does Daniel Gradin, M.D. have Open Payments data?

Daniel Gradin, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.